{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:13:58Z","timestamp":1760955238093},"reference-count":27,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jns.2010.07.025","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T08:18:11Z","timestamp":1282810691000},"page":"101-105","source":"Crossref","is-referenced-by-count":19,"title":["Safety and outcome after thrombolytic treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use"],"prefix":"10.1016","volume":"298","author":[{"given":"Young Dae","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yo Han","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Mo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hoon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Suk","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Yul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hoe","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jns.2010.07.025_bb0005","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","volume":"38","author":"Adams","year":"2007","journal-title":"Stroke"},{"issue":"6 Suppl","key":"10.1016\/j.jns.2010.07.025_bb0010","doi-asserted-by":"crossref","first-page":"630S","DOI":"10.1378\/chest.08-0720","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Albers","year":"2008","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jns.2010.07.025_bb0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000131083","article-title":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008","volume":"25","author":"The European Stroke Oraganisation (ESO) Executive Committee; ESO writing Committee","year":"2008","journal-title":"Cerebrovasc Dis"},{"issue":"5","key":"10.1016\/j.jns.2010.07.025_bb0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000108438","article-title":"Frequency and significance of cardiac sources of embolism in the TOAST classification","volume":"24","author":"Han","year":"2007","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.jns.2010.07.025_bb0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.annemergmed.2005.12.010","article-title":"The prevalence of nontherapeutic and dangerous international normalized ratios among patients receiving warfarin in the emergency department","volume":"48","author":"Newman","year":"2006","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.jns.2010.07.025_bb0030","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1160\/TH08-09-0626","article-title":"Subtherapeutic oral anticoagulant therapy: frequency and risk factors","volume":"101","author":"Rombouts","year":"2009","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.jns.2010.07.025_bb0035","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/STROKEAHA.106.480566","article-title":"Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations","volume":"38","author":"De Keyser","year":"2007","journal-title":"Stroke"},{"issue":"21","key":"10.1016\/j.jns.2010.07.025_bb0040","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.jns.2010.07.025_bb0045","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jns.2010.07.025_bb0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archneur.65.5.noc70077","article-title":"Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke","volume":"65","author":"Uyttenboogaart","year":"2008","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.jns.2010.07.025_bb0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21456","article-title":"Admission international normalized ratio and acute infarct volume in ischemic stroke","volume":"64","author":"Ay","year":"2008","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.jns.2010.07.025_bb0060","first-page":"1470","article-title":"Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke","volume":"25","author":"Lee","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.jns.2010.07.025_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"24","key":"10.1016\/j.jns.2010.07.025_bb0070","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"issue":"9558","key":"10.1016\/j.jns.2010.07.025_bb0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study","volume":"369","author":"Wahlgren","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jns.2010.07.025_bb0080","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1212\/WNL.57.11.1993","article-title":"Oral anticoagulation for cerebral ischemia of arterial origin: high initial bleeding risk","volume":"57","author":"Torn","year":"2001","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jns.2010.07.025_bb0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJM199608223350802","article-title":"An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation","volume":"335","author":"Hylek","year":"1996","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jns.2010.07.025_bb0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199507063330102","article-title":"Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group","volume":"333","author":"Group","year":"1995","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jns.2010.07.025_bb0095","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/hrt.2005.062158","article-title":"Is warfarin a contraindication to thrombolysis in acute ST elevation myocardial infarction?","volume":"92","author":"Stanley","year":"2006","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.jns.2010.07.025_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000083181","article-title":"Intra-arterial thrombolysis in patients treated with warfarin","volume":"19","author":"Linfante","year":"2005","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"10.1016\/j.jns.2010.07.025_bb0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF02934752","article-title":"Acute ischaemic stroke treated with combined intra-arterial thrombolysis and intravenous tirofiban despite oral anticoagulant therapy at an international normalised ratio > or = 2.0","volume":"1","author":"Del Pace","year":"2006","journal-title":"Intern Emerg Med"},{"issue":"11","key":"10.1016\/j.jns.2010.07.025_bb0110","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1161\/STROKEAHA.109.562769","article-title":"Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants","volume":"40","author":"Rizos","year":"2009","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jns.2010.07.025_bb0115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1747-4949.2009.00331.x","article-title":"Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network","volume":"4","author":"Dowlatshahi","year":"2009","journal-title":"Int J Stroke"},{"issue":"5","key":"10.1016\/j.jns.2010.07.025_bb0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archneurol.2010.25","article-title":"Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke","volume":"67","author":"Prabhakaran","year":"2010","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.jns.2010.07.025_bb0125","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1161\/STROKEAHA.107.510321","article-title":"Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study","volume":"39","author":"Paciaroni","year":"2008","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.jns.2010.07.025_bb0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/jnnp.2005.070292","article-title":"Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre","volume":"77","author":"van Oostenbrugge","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2010.07.025_bb0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","article-title":"PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism","volume":"29","author":"del Zoppo","year":"1998","journal-title":"Stroke"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X10003485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X10003485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T08:40:26Z","timestamp":1559464826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X10003485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":27,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0022510X10003485"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2010.07.025","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}